User profiles for Viviana Cobos Jiménez
 | Viviana Cobos JimenezScientist at Viroclinics Verified email at viroclinics.com Cited by 1626 |
Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences
…, NH Ten Hacken, V Cobos Jiménez… - Blood, The Journal …, 2013 - ashpublications.org
The molecular repertoire of macrophages in health and disease can provide novel biomarkers
for diagnosis, prognosis, and treatment. Th2-IL-4–activated macrophages (M2) have …
for diagnosis, prognosis, and treatment. Th2-IL-4–activated macrophages (M2) have …
[HTML][HTML] Dissection of the influenza A virus endocytic routes reveals macropinocytosis as an alternative entry pathway
…, DM Tscherne, MJ Wienholts, V Cobos-Jiménez… - PLoS …, 2011 - journals.plos.org
Influenza A virus (IAV) enters host cells upon binding of its hemagglutinin glycoprotein to
sialylated host cell receptors. Whereas dynamin-dependent, clathrin-mediated endocytosis (…
sialylated host cell receptors. Whereas dynamin-dependent, clathrin-mediated endocytosis (…
Next-generation sequencing of microRNAs uncovers expression signatures in polarized macrophages
V Cobos Jiménez, EJ Bradley… - Physiological …, 2014 - journals.physiology.org
microRNAs (miRNAs) are small noncoding RNAs that regulate gene expression at a
posttranscriptional level and play a crucial role in the development of cells of the immune system. …
posttranscriptional level and play a crucial role in the development of cells of the immune system. …
[HTML][HTML] Differential expression of HIV-1 interfering factors in monocyte-derived macrophages stimulated with polarizing cytokines or interferons
V Cobos Jiménez, T Booiman, SW de Taeye… - Scientific reports, 2012 - nature.com
HIV-1 replication in macrophages can be regulated by cytokines and infection is restricted
in macrophages activated by type I interferons and polarizing cytokines. Here, we observed …
in macrophages activated by type I interferons and polarizing cytokines. Here, we observed …
[HTML][HTML] Post-vaccination T cell immunity to omicron
H Jacobsen, V Cobos Jiménez, I Sitaras… - Frontiers in …, 2022 - frontiersin.org
In late 2021, the omicron variant of SARS Coronavirus 2 (SARS-CoV-2) emerged and
replaced the previously dominant delta strain. Effectiveness of COVID-19 vaccines against …
replaced the previously dominant delta strain. Effectiveness of COVID-19 vaccines against …
Creation of a nonspreading Rift Valley fever virus
J Kortekaas, N Oreshkova, V Cobos-Jiménez… - Journal of …, 2011 - Am Soc Microbiol
Rift Valley fever virus (RVFV) is a mosquito-borne zoonotic bunyavirus of the genus Phlebovirus
and a serious human and veterinary pathogen. RVFV contains a three-segmented RNA …
and a serious human and veterinary pathogen. RVFV contains a three-segmented RNA …
[HTML][HTML] Systematic review and meta-analysis of the factors affecting waning of post-vaccination neutralizing antibody responses against SARS-CoV-2
H Jacobsen, I Sitaras, M Katzmarzyk, V Cobos Jiménez… - npj Vaccines, 2023 - nature.com
Mass COVID-19 vaccination and continued introduction of new SARS-CoV-2 variants increased
prevalence of hybrid immunity at various stages of waning protection. We systematically …
prevalence of hybrid immunity at various stages of waning protection. We systematically …
[HTML][HTML] Post-vaccination neutralization responses to Omicron sub-variants
H Jacobsen, M Katzmarzyk, MM Higdon, VC Jiménez… - Vaccines, 2022 - mdpi.com
Background: The emergence of the Omicron variant (B.1.1.529), which correlated with dramatic
losses in cross-neutralization capacity of post-vaccination sera, raised concerns about …
losses in cross-neutralization capacity of post-vaccination sera, raised concerns about …
Macrophages and HIV-1
V Cobos-Jiménez, T Booiman, J Hamann… - Current Opinion in …, 2011 - journals.lww.com
Under combined antiretroviral therapy (cART), HIV-1 continues to persist in macrophages.
Better understanding of HIV-1 infection in macrophages may lead to new adjunctive therapies …
Better understanding of HIV-1 infection in macrophages may lead to new adjunctive therapies …
[HTML][HTML] G3BP1 restricts HIV-1 replication in macrophages and T-cells by sequestering viral RNA
VC Jiménez, FO Martinez, T Booiman, KA van Dort… - Virology, 2015 - Elsevier
HIV-1 exploits the cellular machinery for replication and therefore several interactions with
cellular factors take place, some of which are yet unknown. We identified GTPase-activating …
cellular factors take place, some of which are yet unknown. We identified GTPase-activating …
